Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lother SA"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.
Autorzy:
Lofgren SM; University of Minnesota, Minneapolis, Minnesota, USA.
Nicol MR; University of Minnesota, Minneapolis, Minnesota, USA.
Bangdiwala AS; University of Minnesota, Minneapolis, Minnesota, USA.
Pastick KA; University of Minnesota, Minneapolis, Minnesota, USA.
Okafor EC; University of Minnesota, Minneapolis, Minnesota, USA.
Skipper CP; University of Minnesota, Minneapolis, Minnesota, USA.
Pullen MF; University of Minnesota, Minneapolis, Minnesota, USA.
Engen NW; University of Minnesota, Minneapolis, Minnesota, USA.
Abassi M; University of Minnesota, Minneapolis, Minnesota, USA.
Williams DA; University of Minnesota, Minneapolis, Minnesota, USA.
Nascene AA; University of Minnesota, Minneapolis, Minnesota, USA.
Axelrod ML; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Lother SA; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
MacKenzie LJ; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Drobot G; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Marten N; George & Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba, Canada.
Cheng MP; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Zarychanski R; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.; George & Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba, Canada.
Schwartz IS; Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Silverman M; Lawson Research Institute, St. Joseph's Healthcare Center, London, Ontario.
Chagla Z; McMaster University, Hamilton, Ontario, Canada.
Kelly LE; George & Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba, Canada.
McDonald EG; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Lee TC; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Hullsiek KH; University of Minnesota, Minneapolis, Minnesota, USA.
Boulware DR; University of Minnesota, Minneapolis, Minnesota, USA.
Rajasingham R; University of Minnesota, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Oct 19; Vol. 7 (11), pp. ofaa500. Date of Electronic Publication: 2020 Oct 19 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19).
Autorzy:
Pastick KA; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Okafor EC; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Wang F; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota.
Lofgren SM; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Skipper CP; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Nicol MR; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota.
Pullen MF; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Rajasingham R; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
McDonald EG; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, Canada.
Lee TC; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, Canada.
Schwartz IS; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta.
Kelly LE; Department of Pediatrics and Child Health, Department of Pharmacology, University of Manitoba, Winnipeg, Canada.
Lother SA; Department of Medicine, Sections of Critical Care and Infectious Diseases, University of Manitoba, Winnipeg, Canada.
Mitjà O; Fight AIDS and Inf Dis Foundation, Hospital Germans Trias i Pujol, Barcelona, Spain.
Letang E; Department of Infectious Diseases, Hospital del Mar/Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; ISGlobal, Barcelona Institute for Global Health, Universitat de Barcelona, Barcelona, Spain.
Abassi M; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Boulware DR; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Apr 15; Vol. 7 (4), pp. ofaa130. Date of Electronic Publication: 2020 Apr 15 (Print Publication: 2020).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies